These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11580304)

  • 1. Recombinant relaxin: a review of pharmacology and potential therapeutic use.
    Gavino ES; Furst DE
    BioDrugs; 2001; 15(9):609-14. PubMed ID: 11580304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted biological therapies reach the heart: the case of serelaxin for heart failure.
    Kumar VA; Wilson SS; Ayaz SI; Levy PD
    Drugs Today (Barc); 2015 Oct; 51(10):591-7. PubMed ID: 26583301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.
    Seibold JR; Clements PJ; Furst DE; Mayes MD; McCloskey DA; Moreland LW; White B; Wigley FM; Rocco S; Erikson M; Hannigan JF; Sanders ME; Amento EP
    J Rheumatol; 1998 Feb; 25(2):302-7. PubMed ID: 9489823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular system.
    Jelinic M; Marshall SA; Leo CH; Parry LJ; Tare M
    Microcirculation; 2019 Feb; 26(2):e12464. PubMed ID: 29876993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence.
    Ghosh RK; Banerjee K; Tummala R; Ball S; Ravakhah K; Gupta A
    Cardiovasc Ther; 2017 Feb; 35(1):55-63. PubMed ID: 27727514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin: a pleiotropic hormone.
    Bani D
    Gen Pharmacol; 1997 Jan; 28(1):13-22. PubMed ID: 9112071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.
    Nistri S; Bigazzi M; Bani D
    Cardiovasc Hematol Agents Med Chem; 2007 Apr; 5(2):101-8. PubMed ID: 17430134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening.
    Bell RJ; Permezel M; MacLennan A; Hughes C; Healy D; Brennecke S
    Obstet Gynecol; 1993 Sep; 82(3):328-33. PubMed ID: 8355929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs of the future: the hormone relaxin.
    Samuel CS; Hewitson TD; Unemori EN; Tang ML
    Cell Mol Life Sci; 2007 Jun; 64(12):1539-57. PubMed ID: 17458501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs.
    Muppidi A; Lee SJ; Hsu CH; Zou H; Lee C; Pflimlin E; Mahankali M; Yang P; Chao E; Ahmad I; Crameri A; Wang D; Woods A; Shen W
    Bioconjug Chem; 2019 Jan; 30(1):83-89. PubMed ID: 30543420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin in cardiovascular and renal disease.
    Samuel CS; Hewitson TD
    Kidney Int; 2006 May; 69(9):1498-502. PubMed ID: 16672919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries.
    Jeyabalan A; Novak J; Danielson LA; Kerchner LJ; Opett SL; Conrad KP
    Circ Res; 2003 Dec; 93(12):1249-57. PubMed ID: 14593002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin on the beach.
    Ivell R
    Trends Endocrinol Metab; 2001 Apr; 12(3):89-91. PubMed ID: 11351966
    [No Abstract]   [Full Text] [Related]  

  • 14. The physiological role of relaxin in the pregnant rat. IV. The influence of relaxin on cervical collagen and glycosaminoglycans.
    Downing SJ; Sherwood OD
    Endocrinology; 1986 Feb; 118(2):471-9. PubMed ID: 3943482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin and the cervix.
    Weiss G; Goldsmith LT
    Front Horm Res; 2001; 27():105-12. PubMed ID: 11450422
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of relaxin in maternal systemic and renal vascular adaptations during gestation.
    McGuane JT; Debrah JE; Debrah DO; Rubin JP; Segal M; Shroff SG; Conrad KP
    Ann N Y Acad Sci; 2009 Apr; 1160():304-12. PubMed ID: 19416209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual and combined effects of relaxin, estrogen, and progesterone in ovariectomized gilts. I. Effects on the growth, softening, and histological properties of the cervix.
    Winn RJ; Baker MD; Sherwood OD
    Endocrinology; 1994 Sep; 135(3):1241-9. PubMed ID: 8070369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serelaxin and acute heart failure.
    Tietjens J; Teerlink JR
    Heart; 2016 Jan; 102(2):95-9. PubMed ID: 26603680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of relaxin: from basic science to clinical therapy.
    Du XJ; Bathgate RA; Samuel CS; Dart AM; Summers RJ
    Nat Rev Cardiol; 2010 Jan; 7(1):48-58. PubMed ID: 19935741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of serelaxin in patients with severe renal impairment or end-stage renal disease requiring hemodialysis: A single-dose, open-label, parallel-group study.
    Dahlke M; Halabi A; Canadi J; Tsubouchi C; Machineni S; Pang Y
    J Clin Pharmacol; 2016 Apr; 56(4):474-83. PubMed ID: 26239266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.